JOSEPH L HERRING

CIK 1229873 · CEO of Covance Drug Division · last filed 2026-03-09

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$5.50M

Companies

4

Total Filings

56

Lifetime Open-Market Net

-$56.74M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
HSIC Director 31,859 $81.25 $2.59M $127.1K 14 2026-03-09
TMH Director 2,982 $49.12 $146.5K $0 4 2016-05-24
LH CEO of Covance Drug Division 10,404 $266.16 $2.77M -$4.49M 3 2015-08-04
COVANCE INC (CVD) Delisted Chairman and CEO 175,643 -$52.38M 34 2014-12-19

Recent Filings · Page 2 of 6

56 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2017-03-27 HSIC Buy (P) +500 $85.9K EDGAR
2017-03-21 HSIC Grant (A) +500 $85.9K EDGAR
2017-03-08 HSIC Grant (A) +1,084 $0 EDGAR
2016-06-14 HSIC Grant (A) +1,039 $0 EDGAR
2016-05-24 TMH Exer (M) +1,731 $0 EDGAR
2016-03-10 TMH Grant (A) $0 EDGAR
2015-08-04 LH Mixed +10,404 -$1.22M EDGAR
2015-05-26 TMH Grant (A) +2,445 $0 EDGAR
2015-02-27 LH Sell (S) −36,876 -$4.49M EDGAR
2015-02-25 LH Grant (A) $0 EDGAR
Showing 1120 of 56
Page 2 of 6
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.